EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Salmonella Combination Vaccines: Moving Beyond Typhoid

Calman A MacLennan iD, Jeffrey Stanaway, Stephanie Grow, Kirsten Vannice, A Duncan Steele

Open Forum Infectious Diseases · 02.06.2023 · 10 (Supplement_1) · S58-S66

DOI: 10.1093/ofid/ofad041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 02.06.2023. Verfasst von Calman A MacLennan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, Washington, USA. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is now a robust pipeline of licensed and World Health Organization (WHO)–prequalified typhoid conjugate vaccines with a steady progression of national introductions. However, typhoid fever is responsible for less than half the total global burden of Salmonella disease, and even less among children aged <5 years. Invasive nontyphoidal Salmonella disease is the dominant clinical presentation of Salmonella in Africa, and over a quarter of enteric fever in Asia is due to paratyphoid A. In this article, we explore the case for combination Salmonella vaccines, review the current pipeline of these vaccines, and discuss key considerations for their development, including geographies of use, age of administration, and pathways to licensure. While a trivalent typhoid/nontyphoidal Salmonella vaccine is attractive for Africa, and a bivalent enteric fever vaccine for Asia, a quadrivalent vaccine covering the 4 main disease-causing serovars of Salmonella enterica would provide a single vaccine option for global Salmonella coverage.

Schlagwörter

Stichwörter der Autor:innen

Salmonellanontyphoidalparatyphoidtyphoidvaccines

Autor:innen und Institutionen

  • Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, Washington, USA.
  • Jenner Institute, University of Oxford, Oxford, United Kingdom.
  • Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Calman A MacLennan

Förderung

  • Medical Research Council

Zitieren

APA

MacLennan, C. A., Stanaway, J., Grow, S., Vannice, K., & Steele, A. D. (2023). Salmonella Combination Vaccines: Moving Beyond Typhoid. Open Forum Infectious Diseases, 10(Supplement_1), S58-S66. https://doi.org/10.1093/ofid/ofad041

Vancouver

MacLennan CA, Stanaway J, Grow S, Vannice K, Steele AD. Salmonella Combination Vaccines: Moving Beyond Typhoid. Open Forum Infectious Diseases. 2023;10(Supplement_1):S58-S66. doi:10.1093/ofid/ofad041

BibTeX
@article{MacLennan2023,
  author = {MacLennan, Calman A and Stanaway, Jeffrey and Grow, Stephanie and Vannice, Kirsten and Steele, A Duncan},
  title = {Salmonella Combination Vaccines: Moving Beyond Typhoid},
  journal = {Open Forum Infectious Diseases},
  year = {2023},
  volume = {10},
  number = {Supplement_1},
  pages = {S58--S66},
  doi = {10.1093/ofid/ofad041}
}
Kostenlos starten →